The YOLAMIN brand, founded in 2008 (Germany), from 14 sister brands and 2214 competing brands. YOLAMIN is owned by Medigene, listed on the stock exchange of Francfort The ISIN, the company's International Securities Identification Number, is DE000A1X3W00. YOLAMIN is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
Medigene
(YOLAMIN)
over 5 years*
EUR 0.38